行情

TEVA

TEVA

梯瓦制药
NYSE

实时行情|Nasdaq Last Sale

10.10
-0.29
-2.79%
盘后: 9.99 -0.11 -1.09% 19:58 01/24 EST
开盘
10.39
昨收
10.39
最高
10.43
最低
9.94
成交量
1,475.68万
成交额
--
52周最高
20.21
52周最低
6.07
市值
110.30亿
市盈率(TTM)
-2.6364
分时
5日
1月
3月
1年
5年

分析师评级

24位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TEVA 新闻

  • Is Mylan Stock a Buy?
  • MotleyFool.com.1天前
  • Comcast: 5%+ Correction Post Q4 Results Not Justified: Reiterate Buy
  • Seeking Alpha - Article.2天前
  • New partnership aims to ease surging generic drug costs— by making its own
  • Yahoo Finance.2天前
  • Judge OKs ad blitz for opioid epidemic claimants
  • Seeking Alpha - Article.2天前

更多

所属板块

制药
-1.84%
制药与医学研究
-2.00%

热门股票

名称
价格
涨跌幅

TEVA 简况

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women's health and selected other areas.
展开

Webull提供Teva Pharmaceutical Industries Ltd (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。